Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000929

Type of data: Sanger sequencing
Access criteria: Controlled-access (Type I)
Total data volume: 2.2 MB
File formats: AB1
Research: hum0499
Date published: 2025-04-25
Date modified: 2025-04-25
DDBJ Search: JGAD000929 (opens in a new tab)
JGA Study: JGAS000787 (opens in a new tab)

Analysis method

Sanger sequencing

Materials and participants: Sarcoma (ICD10: D48.1): 6 cases, 10 plasma samples; Health status
Affected
Subject count
6 (Individual)
Disease: Sarcoma (D481)
Sample description: cfRNA from plasma samples; Tissue
Plasma
Tumor / normal
Normal
Sample provider: N/A
Experimental method: Sanger sequencing
Target: EWSR1-FLI1, FUS-DDIT3
Reagent kit: BigDye Terminator v3.1 Cycle Sequencing Kit
Platform: Applied Biosystems 3730xl DNA Analyzer
Data use policy: NBDC data sharing policy (JGAP000001)